Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114) Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Gastrectomy
  • Stomach Neoplasms

abstract

  • Though PC appears to be safe and the median DFS favorable, the DFS failed to exceed the lower bound of 52.9% for the targeted 67% DFS at 2 years and can not be recommended as the adjuvant arm for future randomized trials.

publication date

  • April 20, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2669761

Digital Object Identifier (DOI)

  • 10.1200/JCO.2008.20.3745

PubMed ID

  • 19273696

Additional Document Info

start page

  • 1956

end page

  • 62

volume

  • 27

number

  • 12